Teachers Retirement System of The State of Kentucky Sells 6,771 Shares of HealthEquity, Inc. $HQY

Teachers Retirement System of The State of Kentucky lowered its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 14.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 40,612 shares of the company’s stock after selling 6,771 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in HealthEquity were worth $3,848,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. True Wealth Design LLC grew its stake in HealthEquity by 3,522.2% in the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after buying an additional 317 shares in the last quarter. Farther Finance Advisors LLC boosted its position in shares of HealthEquity by 59.3% in the third quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock valued at $37,000 after acquiring an additional 146 shares during the period. AlphaQuest LLC increased its holdings in HealthEquity by 52.2% during the 3rd quarter. AlphaQuest LLC now owns 624 shares of the company’s stock worth $59,000 after acquiring an additional 214 shares during the period. Allworth Financial LP increased its holdings in HealthEquity by 283.1% during the 2nd quarter. Allworth Financial LP now owns 747 shares of the company’s stock worth $78,000 after acquiring an additional 552 shares during the period. Finally, Huntington National Bank lifted its stake in HealthEquity by 119.3% in the 2nd quarter. Huntington National Bank now owns 750 shares of the company’s stock worth $79,000 after purchasing an additional 408 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of the stock in a transaction on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the sale, the executive vice president owned 73,979 shares of the company’s stock, valued at $7,007,290.88. This represents a 1.99% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the transaction, the executive vice president owned 45,742 shares in the company, valued at $4,366,073.90. The trade was a 19.33% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 1.50% of the company’s stock.

HealthEquity Price Performance

HQY opened at $81.15 on Thursday. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $116.65. The stock’s 50 day simple moving average is $83.82 and its 200 day simple moving average is $90.92. The firm has a market cap of $6.93 billion, a price-to-earnings ratio of 37.22, a PEG ratio of 1.00 and a beta of 0.26.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm had revenue of $322.16 million during the quarter, compared to analyst estimates of $320.92 million. During the same quarter in the prior year, the firm posted $0.78 earnings per share. The business’s quarterly revenue was up 7.2% compared to the same quarter last year. As a group, analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on HQY shares. Barclays decreased their price target on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday, February 18th. UBS Group set a $110.00 target price on HealthEquity in a research note on Tuesday, February 17th. Jefferies Financial Group set a $108.00 price target on HealthEquity in a report on Thursday, February 19th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $120.00 price objective on shares of HealthEquity in a report on Friday, December 5th. Finally, The Goldman Sachs Group cut shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price objective on the stock. in a research report on Friday, January 9th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $112.00.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.